SCHEMBL28338332

SCHEMBL28338332

O=C1Nc2ccccc2C(=O)C1F

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LRRK2 Q5S007 2/20 0.45
MAOA P21397 1/20 0.45
MAOB P27338 1/20 0.45
PDGFRA P16234 1/20 0.45
FER P16591 1/20 0.45
LTK P29376 1/20 0.45
CDK8 P49336 1/20 0.45
ACVR1 Q04771 1/20 0.45
DYRK1B Q9Y463 1/20 0.45
BRPF1 P55201 1/20 0.41
CREBBP Q92793 1/20 0.41
LMNA P02545 2/20 0.40
GFER P55789 1/20 0.40
TSHR P16473 1/20 0.40
MEN1 O00255 3/20 0.39
ALDH1A1 P00352 3/20 0.39
KMT2A Q03164 3/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
GSK3B P49841 1/20 0.38
PARP1 P09874 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11012661 0.81 CREBBP (0.54) LRRK2MAOAMAOBPDGFRAFER
SCHEMBL11451121 0.76 CREBBP (0.50) LRRK2MAOAMAOBPDGFRAFER
SCHEMBL30122758 0.76 MAOA (0.45) LRRK2MAOAMAOBPDGFRAFER
SCHEMBL1074137 0.76 LRRK2 (0.45) LRRK2MAOAMAOBPDGFRAFER
SCHEMBL30556308 0.76 MAOA (0.41) LRRK2MAOAMAOBPDGFRAFER
SCHEMBL5144419 0.75 IDO1 (0.50) BRPF1CREBBPALDH1A1L3MBTL1GSK3B
SCHEMBL30364585 0.75 IDO1 (0.50) BRPF1CREBBPALDH1A1L3MBTL1GSK3B
SCHEMBL9393278 0.74 MEN1 (0.59) LRRK2MAOAMAOBPDGFRAFER
SCHEMBL13685637 0.73 MAPT (0.59) LRRK2MAOAMAOBPDGFRAFER
SCHEMBL14375245 0.72 PIM1 (0.60) LRRK2MAOAMAOBPDGFRAFER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110582291-A Reactivity marker and efficacy-improving modulator for anti-PD 1/PD-L1/PD-L2 antibody 古斯达威罗斯研究所 2019-12-17 CN disclosed